Form 4 for TRAW Traws Pharma, Inc.
Accepted 2024-03-15 00:00:00 ET · period of report 2024-03-13 · accession 0001415889-24-008141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-15 | 2024-03-14 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | F - Tax | $0.9 | -8,727 | 74.8K | -10% | -$7,854 |
| D | 2024-03-15 | 2024-03-13 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | M - OptEx | — | +23.1K | 83.5K | +38% | — |
| D | 2024-03-15 | 2024-03-13 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | M - OptEx | $0.00 | -23.1K | 46.2K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-14 | F | D | 8,727 | $0.9 | 74,792 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-13 | M | A | 23,111 | — | 83,519 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Units | 2024-03-13 | M | D | 23,111 | $0.00 | 46,222 | D | — · — to — | 23,111 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On March 13, 2023 the reporting person was granted 69,333 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary. |